These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology.
    Author: Schwab M.
    Journal: Ann N Y Acad Sci; 2002 Jun; 963():63-73. PubMed ID: 12095930.
    Abstract:
    Increase in the dosage of cellular oncogenes by DNA amplification is a frequent genetic alteration of cancer cells. In neuroblastoma, amplification of the gene MYCN has been associated with aggressively growing cancers and is an indicator for poor prognosis. MYCN amplification is of predictive value in identifying patients with neuroblastoma who require specific therapeutic regimens and those who do not benefit from chemotherapy.
    [Abstract] [Full Text] [Related] [New Search]